Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal

Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal -

[1]  W. Ageno,et al.  Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding , 2013, Journal of Thrombosis and Thrombolysis.

[2]  J. Menzin,et al.  Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records , 2012, Journal of thrombosis and haemostasis : JTH.

[3]  Mark Crowther,et al.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[4]  B. Erstad,et al.  Dosing of 3-Factor Prothrombin Complex Concentrate for International Normalized Ratio Reversal , 2012, The Annals of pharmacotherapy.

[5]  W. Ageno,et al.  Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists , 2011, Thrombosis and Haemostasis.

[6]  J. Douketis,et al.  Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment , 2009, American journal of hematology.

[7]  M. Crowther,et al.  Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose , 2009, Transfusion.

[8]  C. Samama.  Prothrombin complex concentrates: a brief review , 2008, European journal of anaesthesiology.

[9]  W. Ageno,et al.  Prothrombin Complex Concentrates for Urgent Anticoagulation Reversal in Patients with Intracranial Haemorrhage , 2007, Pathophysiology of Haemostasis and Thrombosis.

[10]  W. Ageno,et al.  Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms , 2006, Journal of thrombosis and haemostasis : JTH.

[11]  D. Garcia,et al.  A survey of oral vitamin K use by anticoagulation clinics. , 2002, Archives of internal medicine.

[12]  Vittorio Pengo,et al.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.